Response to: Bayesian reappraisal of ACNS0332 and ACNS0334 strengthens subgroup treatment effects in high-risk pediatric group 3 medulloblastoma
- 29 September 2025
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 27 (12) , 3321
Abstract
No abstract availableFunding Information
- National Institutes of Health (U10CA180899)
- Statistics & Data Center (5R50CA275857-02)
This publication has 2 references indexed in Scilit: